- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Novel therapeutic strategies targeting HIV integrase ; volume:10 ; number:1 ; day:12 ; month:4 ; year:2012 ; pages:1-11 ; date:12.2012
BMC medicine ; 10, Heft 1 (12.4.2012), 1-11, 12.2012
- Urheber
-
Quashie, Peter K.
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/1741-7015-10-34
- URN
-
urn:nbn:de:1111-2016072946637
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Quashie, Peter K.
- Sloan, Richard D.
- Wainberg, Mark A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Integrase and integration: biochemical activities of HIV-1 integrase
PIAS3 modulate HIV-1 integrase SUMOylation
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
Therapeutic strategies targeting Kv10.1 in PDAC
HIV-1 integrase SUMOylation and viral replication
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Drug resistant integrase mutants cause aberrant HIV integrations
Update on Adverse Effects of HIV Integrase Inhibitors
HIV drug resistance against strand transfer integrase inhibitors
Integrase and integration: biochemical activities of HIV-1 integrase
PIAS3 modulate HIV-1 integrase SUMOylation
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
Therapeutic strategies targeting Kv10.1 in PDAC
HIV-1 integrase SUMOylation and viral replication
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Drug resistant integrase mutants cause aberrant HIV integrations
Update on Adverse Effects of HIV Integrase Inhibitors
HIV drug resistance against strand transfer integrase inhibitors
Integrase and integration: biochemical activities of HIV-1 integrase
PIAS3 modulate HIV-1 integrase SUMOylation
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
Therapeutic strategies targeting Kv10.1 in PDAC
HIV-1 integrase SUMOylation and viral replication
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of an Atropisomeric HIV Integrase Inhibitor
Synthesis of HIV Integrase Inhibitor MK-1376
Drug resistant integrase mutants cause aberrant HIV integrations
Update on Adverse Effects of HIV Integrase Inhibitors